Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Learning curve
The outcome of a company's experience when developing a product - typically, a graph of the amount of material learned, plotted against time.
See also:
Learning log
Related terms
Dodo, Comparative advertising, Distribution, Differentiation, Brand value, Cognitive dissonance, Free market economy, Launch, Added value, Customer lifetime value (CLV), Product differentiation, Brand management , Adopter categories, Concept boards, Opportunity cost,
COVID-19 Updates and Daily News
Featured jobs
-
Head of Copy
-
£ competitive
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- AstraZeneca's Enhertu receives FDA grant for priority review
- AstraZeneca’s Vaxzevria trial provides further support for protection against COVID-19 variants
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- BioNTech and InstaDeep collaboration develops SARS-CoV-2 Early Warning System
- Vir Biotech launches new research programme for HIV and malaria prevention
- Why pharma must get smart in its approach to customer engagement
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Almirall and IRB Barcelona announce new research collaboration
- 6 critical success factors for flawless execution of a rapid first commercial launch
- Meet Innovative Trials at SCOPE 2022
- We let your whole self shine
- EMA proposes EU clinical trial reforms
- Why pharma must get smart in its approach to customer engagement
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy
- EU cross-border healthcare
- The true meaning of market access?
